The applications of Vitamin E TPGS in drug delivery.

[1]  S. Feng,et al.  Vitamin E TPGS prodrug micelles for hydrophilic drug delivery with neuroprotective effects. , 2012, International journal of pharmaceutics.

[2]  I. Ghosh,et al.  A comparative study of Vitamin E TPGS/HPMC supersaturated system and other solubilizer/polymer combinations to enhance the permeability of a poorly soluble drug through the skin , 2012, Drug development and industrial pharmacy.

[3]  Si-Shen Feng,et al.  Vitamin E TPGS as a molecular biomaterial for drug delivery. , 2012, Biomaterials.

[4]  P. Stein,et al.  Overcoming instability and low solubility of new cytostatic compounds: a comparison of two approaches. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  Stephen T Buckley,et al.  In vitro models to evaluate the permeability of poorly soluble drug entities: challenges and perspectives. , 2012, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[6]  S. Kadam,et al.  In Vivo Evaluation of the Biocompatibility of Surface Modified Hemodialysis Polysulfone Hollow Fibers in Rat , 2011, PloS one.

[7]  M. Brandl,et al.  Effect of the non-ionic surfactant Poloxamer 188 on passive permeability of poorly soluble drugs across Caco-2 cell monolayers. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[8]  Hongzhuo Liu,et al.  Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems , 2011, Drug development and industrial pharmacy.

[9]  M. Brandl,et al.  In‐vitro permeability of poorly water soluble drugs in the phospholipid vesicle‐based permeation assay: the influence of nonionic surfactants , 2011, The Journal of pharmacy and pharmacology.

[10]  R. Banerjee,et al.  Effect of D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) on surfactant monolayers. , 2011, Colloids and surfaces. B, Biointerfaces.

[11]  Xing Tang,et al.  Bioavailability Study of Berberine and the Enhancing Effects of TPGS on Intestinal Absorption in Rats , 2011, AAPS PharmSciTech.

[12]  S. Feng,et al.  Formulation of Docetaxel by folic acid-conjugated d-α-tocopheryl polyethylene glycol succinate 2000 (Vitamin E TPGS(2k)) micelles for targeted and synergistic chemotherapy. , 2011, Biomaterials.

[13]  K. Kim,et al.  Absorption Enhancer and Polymer (Vitamin E TPGS and PVP K29) by Solid Dispersion Improve Dissolution and Bioavailability of Eprosartan Mesylate , 2011 .

[14]  I. Ghosh,et al.  Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth. , 2011, International journal of pharmaceutics.

[15]  Werner Weitschies,et al.  Effects of non-ionic surfactants on cytochrome P450-mediated metabolism in vitro. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  W. Weitschies,et al.  Investigating the stability of the nonionic surfactants tocopheryl polyethylene glycol succinate and sucrose laurate by HPLC-MS, DAD, and CAD. , 2011, Journal of pharmaceutical sciences.

[17]  F. Ahmad,et al.  The emerging role of P-glycoprotein inhibitors in drug delivery: a patent review , 2011, Expert opinion on therapeutic patents.

[18]  A. Dokoumetzidis,et al.  Supersaturated dissolution data and their interpretation: the TPGS–carbamazepine model case , 2011, The Journal of pharmacy and pharmacology.

[19]  Chien‐Ho Chen,et al.  Characterisation of fenofibrate dissolution delivered by a self‐microemulsifying drug‐delivery system , 2010, The Journal of pharmacy and pharmacology.

[20]  W. Weitschies,et al.  Effects of non-ionic surfactants on in vitro triglyceride digestion and their susceptibility to digestion by pancreatic enzymes. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  Werner Weitschies,et al.  Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2). , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  Aiguo Li,et al.  Preparation, characterization, pharmacokinetics, and tissue distribution of curcumin nanosuspension with TPGS as stabilizer , 2010, Drug development and industrial pharmacy.

[23]  Hui Xu,et al.  Efficient dispersing and shortening of super-growth carbon nanotubes by ultrasonic treatment with ceramic balls and surfactants , 2010 .

[24]  H. Thomas,et al.  Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis. , 2010, Journal of hepatology.

[25]  F. Liu,et al.  Paclitaxel nanocrystals for overcoming multidrug resistance in cancer. , 2010, Molecular pharmaceutics.

[26]  B. Goderis,et al.  Lyotropic, liquid crystalline nanostructures of aqueous dilutions of SMEDDS revealed by small-angle X-ray scattering: impact on solubility and drug release. , 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[27]  Claus-Michael Lehr,et al.  Vitamin E TPGS P-glycoprotein inhibition mechanism: influence on conformational flexibility, intracellular ATP levels, and role of time and site of access. , 2010, Molecular pharmaceutics.

[28]  F. Narjes,et al.  Enhancement of intestinal absorption of 2-methyl cytidine prodrugs , 2010, Drug delivery.

[29]  A. Tatavarti,et al.  Tabletability assessment of conventional formulations containing Vitamin E tocopheryl polyethylene glycol succinate. , 2010, International journal of pharmaceutics.

[30]  Yong Eun Chung,et al.  Feasibility of Interstitial CT Lymphography Using Optimized Iodized Oil Emulsion in Rats , 2010, Investigative radiology.

[31]  Mariarosa Moneghini,et al.  Characterization of solid dispersions of itraconazole and vitamin E TPGS prepared by microwave technology. , 2010, Future medicinal chemistry.

[32]  R. Borchardt,et al.  Absorption barriers in the rat intestinal mucosa. 3: Effects of polyethoxylated solubilizing agents on drug permeation and metabolism. , 2010, Journal of pharmaceutical sciences.

[33]  Sung-Joo Hwang,et al.  Enhancement of wettability and dissolution properties of cilostazol using the supercritical antisolvent process: effect of various additives. , 2010, Chemical & pharmaceutical bulletin.

[34]  M. Sheu,et al.  Correlation of the penetration enhancement with the influence of an alcohol/tocopheryl polyethylene glycol succinate (TPGS) cosolvent system on the molecular structure of the stratum corneum of nude mouse skin as examined by microscopic FTIR/DSC. , 2009, Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy.

[35]  B. Kalikstad,et al.  Dosage and formulation issues: oral vitamin E therapy in children , 2009, European Journal of Clinical Pharmacology.

[36]  Ludo Froyen,et al.  Itraconazole/TPGS/Aerosil200 solid dispersions: characterization, physical stability and in vivo performance. , 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[37]  A. Munck,et al.  Bioavailability of oral vitamin E formulations in adult volunteers and children with chronic cholestasis or cystic fibrosis , 2009, Journal of clinical pharmacy and therapeutics.

[38]  Lieven Baert,et al.  Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[39]  Ludo Froyen,et al.  A screening study of surface stabilization during the production of drug nanocrystals. , 2009, Journal of pharmaceutical sciences.

[40]  M. Sadoqi,et al.  Investigation of the micellar properties of the tocopheryl polyethylene glycol succinate surfactants TPGS 400 and TPGS 1000 by steady state fluorometry. , 2009, Journal of colloid and interface science.

[41]  C. Nacy,et al.  Activity of SQ641, a Capuramycin Analog, in a Murine Model of Tuberculosis , 2009, Antimicrobial Agents and Chemotherapy.

[42]  A. Almurshedi,et al.  The influence of various amphiphilic excipients on the physicochemical properties of carbamazepine-loaded microparticles , 2009, Journal of microencapsulation.

[43]  James L. Little,et al.  Inhibiting efflux with novel non-ionic surfactants: Rational design based on vitamin E TPGS. , 2009, International journal of pharmaceutics.

[44]  K. Houthoofd,et al.  Dissolution enhancement of the anti-HIV drug UC 781 by formulation in a ternary solid dispersion with TPGS 1000 and Eudragit E100. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[45]  L. Froyen,et al.  Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions - a case study with itraconazole. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[46]  C. Goddeeris,et al.  Free flowing solid dispersions of the anti-HIV drug UC 781 with Poloxamer 407 and a maximum amount of TPGS 1000: investigating the relationship between physicochemical characteristics and dissolution behaviour. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[47]  L. Froyen,et al.  Drying of crystalline drug nanosuspensions-the importance of surface hydrophobicity on dissolution behavior upon redispersion. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[48]  C. Goddeeris,et al.  Formulation of fast disintegrating tablets of ternary solid dispersions consisting of TPGS 1000 and HPMC 2910 or PVPVA 64 to improve the dissolution of the anti-HIV drug UC 781. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[49]  A. Van Schepdael,et al.  Formulation and characterization of ternary solid dispersions made up of Itraconazole and two excipients, TPGS 1000 and PVPVA 64, that were selected based on a supersaturation screening study. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[50]  S. Feng,et al.  d-alpha-Tocopheryl polyethylene glycol 1000 succinate (TPGS) modified poly(l-lactide) (PLLA) films for localized delivery of paclitaxel. , 2008, International journal of pharmaceutics.

[51]  Yuichi Sugiyama,et al.  Effect of excipients on breast cancer resistance protein substrate uptake activity. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[52]  R. Hurt,et al.  Tocopheryl Polyethylene Glycol Succinate as a Safe, Antioxidant Surfactant for Processing Carbon Nanotubes and Fullerenes. , 2007, Carbon.

[53]  Geert Verreck,et al.  Use of a screening method to determine excipients which optimize the extent and stability of supersaturated drug solutions and application of this system to solid formulation design. , 2007, International journal of pharmaceutics.

[54]  B. Conway,et al.  Microemulsions as topical delivery vehicles for the anti‐melanoma prodrug, temozolomide hexyl ester (TMZA‐HE) , 2007, The Journal of pharmacy and pharmacology.

[55]  E. Ravichandran,et al.  Trivalent Vaccine against Botulinum Toxin Serotypes A, B, and E That Can Be Administered by the Mucosal Route , 2007, Infection and Immunity.

[56]  R. Kappl,et al.  Mechanism of inhibition of P-glycoprotein mediated efflux by vitamin E TPGS: influence on ATPase activity and membrane fluidity. , 2007, Molecular pharmaceutics.

[57]  J. Kalbfleisch,et al.  Bioavailability of a Novel, Water-Soluble Vitamin E Formulation in Malabsorbing Patients , 2007, Digestive Diseases and Sciences.

[58]  C. Porter,et al.  Permeability assessment of poorly water-soluble compounds under solubilizing conditions: the reciprocal permeability approach. , 2006, Journal of pharmaceutical sciences.

[59]  F. Dosio,et al.  Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.

[60]  Mandip Singh,et al.  Inhalation Delivery and Anti-tumor Activity of Celecoxib in Human Orthotopic Non-Small Cell Lung Cancer Xenograft Model , 2006, Pharmaceutical Research.

[61]  A. Basit,et al.  Impact of formulation excipients on human intestinal transit , 2006, The Journal of pharmacy and pharmacology.

[62]  A. Khanna,et al.  Beneficial Effect of α-Tocopheryl Succinate in Rat Cardiac Transplants , 2006 .

[63]  J. Dressman,et al.  Development of an in vitro/in vivo correlation for lipid formulations of EMD 50733, a poorly soluble, lipophilic drug substance. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[64]  M. Wempe,et al.  Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[65]  Patrick Augustijns,et al.  Intraluminal drug and formulation behavior and integration in in vitro permeability estimation: a case study with amprenavir. , 2006, Journal of pharmaceutical sciences.

[66]  M. Stern,et al.  Can changes in hydrophobicity increase the bioavailability of α–tocopherol? , 2006 .

[67]  S. Davis,et al.  Advances in the Use of Tocols as Drug Delivery Vehicles , 2006, Pharmaceutical Research.

[68]  H. Zia,et al.  Mechanistic Study of Solubility Enhancement of Nifedipine Using Vitamin E TPGS or Solutol HS-15 , 2006, Drug delivery.

[69]  M. Sheu,et al.  Effect of Tocopheryl Polyethylene Glycol Succinate on the Percutaneous Penetration of Minoxidil from Water/Ethanol/Polyethylene Glycol 400 Solutions , 2006, Drug development and industrial pharmacy.

[70]  N. Barakat,et al.  Etodolac-Liquid-Filled Dispersion into Hard Gelatin Capsules: An Approach to Improve Dissolution and Stability of Etodolac Formulation , 2006, Drug development and industrial pharmacy.

[71]  Chien‐Ho Chen,et al.  Simultaneous effects of tocopheryl polyethylene glycol succinate (TPGS) on local hair growth promotion and systemic absorption of topically applied minoxidil in a mouse model. , 2005, International journal of pharmaceutics.

[72]  R. Sokol,et al.  Comparison of indices of vitamin A status in children with chronic liver disease , 2005, Hepatology.

[73]  So H. Kim,et al.  Enhanced anticancer efficacy of α-tocopheryl succinate by conjugation with polyethylene glycol , 2005 .

[74]  Abdul W Basit,et al.  Excipient effects on gastrointestinal transit and drug absorption in beagle dogs. , 2005, International journal of pharmaceutics.

[75]  O. Alpar,et al.  Effect of vitamin E TPGS on immune response to nasally delivered diphtheria toxoid loaded poly(caprolactone) microparticles. , 2005, International journal of pharmaceutics.

[76]  M. Varma,et al.  Enhanced oral paclitaxel absorption with vitamin E-TPGS: effect on solubility and permeability in vitro, in situ and in vivo. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[77]  Shyr‐Yi Lin,et al.  Physical characterizations of microemulsion systems using tocopheryl polyethylene glycol 1000 succinate (TPGS) as a surfactant for the oral delivery of protein drugs. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[78]  Gérard Hopfgartner,et al.  P‐Glycoprotein and Surfactants: Effect on Intestinal Talinolol Absorption , 2005, Clinical pharmacology and therapeutics.

[79]  E. Squillante,et al.  In vitro-in vivo evaluation of supercritical processed solid dispersions: permeability and viability assessment in Caco-2 cells. , 2004, Journal of pharmaceutical sciences.

[80]  C. Rocha,et al.  Pre-clinical and clinical evaluation of solution and soft gelatin capsule formulations for a BCS class 3 compound with atypical physicochemical properties. , 2004, Journal of pharmaceutical sciences.

[81]  Georges Houin,et al.  Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. , 2004, International journal of pharmaceutics.

[82]  E. Squillante,et al.  Solid dispersion of carbamazepine in PVP K30 by conventional solvent evaporation and supercritical methods. , 2004, International journal of pharmaceutics.

[83]  F. Ollevier,et al.  Oral vaccination of African catfish with Vibrio anguillarum O2: effect on antigen uptake and immune response by absorption enhancers in lag time coated pellets. , 2004, Fish & shellfish immunology.

[84]  I. Trocóniz,et al.  Intestinal absorption of penclomedine from lipid vehicles in the conscious rat: contribution of emulsification versus digestibility. , 2004, International journal of pharmaceutics.

[85]  R. Strickley.  Solubilizing Excipients in Oral and Injectable Formulations , 2004, Pharmaceutical Research.

[86]  Y. Lo,et al.  Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[87]  Jochem Alsenz,et al.  The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. , 2003, Journal of pharmaceutical sciences.

[88]  Ling-chun Chen,et al.  Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[89]  P. Kuchel,et al.  NMR Study of the Association of Propofol with Nonionic Surfactants , 2003 .

[90]  Jin Kim,et al.  Physicochemical characterization of solid dispersion of furosemide with TPGS. , 2003, International journal of pharmaceutics.

[91]  Kanji Takada,et al.  Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats. , 2003, International journal of pharmaceutics.

[92]  W. Trommer,et al.  Role of antioxidants in the O-hydroxyethyl-D-(Ser)8-cyclosporine A (SDZ IMM125)-induced apoptosis in rat hepatocytes. , 2002, Biochemical pharmacology.

[93]  Christopher J. H. Porter,et al.  An in vitro examination of the impact of polyethylene glycol 400, pluronic P85, and vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate on P-glycoprotein efflux and enterocyte-based metabolism in excised rat intestine , 2002, AAPS PharmSci.

[94]  Feng Zhang,et al.  Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. , 2002, Biomaterials.

[95]  Susan D. Wong,et al.  Sirolimus Oral Absorption in Rats Is Increased by Ketoconazole but Is Not Affected by d-α-Tocopheryl Poly(Ethylene Glycol 1000) Succinate , 2002, Journal of Pharmacology and Experimental Therapeutics.

[96]  Emilio Squillante,et al.  Physicochemical characterization of solid dispersions of carbamazepine formulated by supercritical carbon dioxide and conventional solvent evaporation method. , 2002, Journal of pharmaceutical sciences.

[97]  James E Polli,et al.  Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[98]  Ronald T Borchardt,et al.  A comparison of commonly used polyethoxylated pharmaceutical excipients on their ability to inhibit P-glycoprotein activity in vitro. , 2002, Journal of pharmaceutical sciences.

[99]  E. De Clercq,et al.  Intestinal absorption characteristics of the low solubility thiocarboxanilide UC-781. , 2002, International journal of pharmaceutics.

[100]  H. Kristensen,et al.  The effect of α-tocopherol on the in vitro solubilisation of lipophilic drugs , 2001 .

[101]  M. Repka,et al.  Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[102]  U. Brinkmann,et al.  ABC drug transporters: hereditary polymorphisms and pharmacological impact in MDR1, MRP1 and MRP2. , 2001, Pharmacogenomics.

[103]  F. A. Mohammed.  Topical Permeation Characteristics of Diclofenac Sodium from NaCMC Gels in Comparison with Conventional Gel Formulations , 2001, Drug development and industrial pharmacy.

[104]  C. Porter,et al.  The formulation of Halofantrine as either non-solubilizing PEG 6000 or solubilizing lipid based solid dispersions: physical stability and absolute bioavailability assessment. , 2000, International journal of pharmaceutics.

[105]  M. Repka,et al.  Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion. , 2000, International journal of pharmaceutics.

[106]  Lawrence X. Yu,et al.  Vitamin E-TPGS Increases Absorption Flux of an HIV Protease Inhibitor by Enhancing Its Solubility and Permeability1 , 1999, Pharmaceutical Research.

[107]  J. Silverman,et al.  Inhibition of P-Glycoprotein by D-α-Tocopheryl Polyethylene Glycol 1000 Succinate (TPGS) , 1999, Pharmaceutical Research.

[108]  M. Plauth,et al.  ESPEN guidelines for nutrition in liver disease and transplantation. , 1997, Clinical nutrition.

[109]  W. Trommer,et al.  Cyclosporine A-induced oxidative stress in rat hepatocytes. , 1997, The Journal of pharmacology and experimental therapeutics.

[110]  L. Benet,et al.  The effect of water‐soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers , 1996, Clinical pharmacology and therapeutics.

[111]  P. Rosenthal,et al.  Enhanced Oral Cyclosporine Absorption With Water‐Soluble Vitamin E Early After Liver Transplantation , 1996, Pharmacotherapy.

[112]  A. Croockewit,et al.  Should hematopoietic growth factors routinely be given concurrently with cytotoxic chemotherapy? , 1996, Clinical pharmacology and therapeutics.

[113]  F. Suchy,et al.  Multicenter trial of d-alpha-tocopheryl polyethylene glycol 1000 succinate for treatment of vitamin E deficiency in children with chronic cholestasis. , 1993, Gastroenterology.

[114]  S. Mizrahi,et al.  Use of water-soluble liquid vitamin E to enhance cyclosporine absorption in children after liver transplant. , 1993, Transplantation proceedings.

[115]  B. Hollis,et al.  d-α-Tocopheryl Polyethylene Glycol-1000 Succinate Enhances the Absorption of Vitamin D in Chronic Cholestatic Liver Disease of Infancy and Childhood , 1992, Pediatric Research.

[116]  R. Sokol,et al.  Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E , 1991, The Lancet.

[117]  M. Green,et al.  Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats. , 1986, The American journal of clinical nutrition.

[118]  C. Terhaar,et al.  d-alpha-Tocopheryl poly(ethylene glycol) 1000 succinate. Acute toxicity, subchronic feeding, reproduction, and teratologic studies in the rat. , 1977, Journal of agricultural and food chemistry.

[119]  S. Kadam,et al.  The biocompatibility and separation performance of antioxidative polysulfone/vitamin E TPGS composite hollow fiber membranes. , 2011, Biomaterials.

[120]  M. Kuentz,et al.  Oral self-emulsifying drug delivery systems, from biopharmaceutical to technical formulation aspects , 2011 .

[121]  A. Kiriyama,et al.  Pharmacokinetic Profiles of Coenzyme Q10: Absorption of Three Different Oral Formulations in Rats , 2009 .

[122]  C. Porter,et al.  Use of plasma proteins as solubilizing agents in in vitro permeability experiments: correction for unbound drug concentration using the reciprocal permeability approach. , 2008, Journal of pharmaceutical sciences.

[123]  M. Kuentz,et al.  Drug-excipient interactions by Vitamin E-TPGS: in vitro studies on inhibition of P-glycoprotein and colonic drug absorption , 2008 .

[124]  R. Panchagnula,et al.  Nanoemulsions as versatile formulations for paclitaxel delivery: peroral and dermal delivery studies in rats. , 2007, The Journal of investigative dermatology.

[125]  R. Casagrande,et al.  Influence of Vehicle on Antioxidant Activity of Quercetin: A Liquid Crystalline Formulation , 2007 .

[126]  L. Freeman,et al.  Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine a in healthy dogs. , 2002, Veterinary therapeutics : research in applied veterinary medicine.

[127]  Susan D. Wong,et al.  Peppermint oil enhances cyclosporine oral bioavailability in rats: comparison with D-alpha-tocopheryl poly(ethylene glycol 1000) succinate (TPGS) and ketoconazole. , 2002, Journal of pharmaceutical sciences.

[128]  S. H. Wu,et al.  Characteristics of D-α-tocopheryl PEG 1000 succinate for applications as an absorption enhancer in drug delivery systems , 1999 .

[129]  B. Koletzko,et al.  Treatment of cholestatic children with water-soluble vitamin E (alpha-tocopheryl polyethylene glycol succinate): effects on serum vitamin E, lipid peroxides, and polyunsaturated fatty acids. , 1997, Journal of pediatric gastroenterology and nutrition.